Guardant Health (NASDAQ: GH) director sells 348 company shares

Rhea-AI Filing Summary

Guardant Health director Tariq Musa reported an open-market sale of 348 shares of Guardant Health common stock on March 18, 2026, at an average price of $88.09 per share. After this transaction, he directly holds 8,394 shares of the company’s stock.

Insider Trade Summary 10b5-1

Net Seller: 348 shares ($30,655)

Net Sell 1 txn

Insider Tariq Musa

Role Director

Sold 348 shs ($31K)

Type	Security	Shares	Price	Value
Sale	Common Stock	348	$88.09	$31K

Holdings After Transaction: Common Stock — 8,394 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tariq Musa

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S		348	D	$88.09	8,394	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Musa Tariq	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Guardant Health (GH) director Tariq Musa report?

Director Tariq Musa reported an open-market sale of Guardant Health common stock. He sold 348 shares in a single transaction, as disclosed in a Form 4 insider filing with regulators.

How many Guardant Health (GH) shares did Tariq Musa sell and at what price?

Tariq Musa sold 348 shares of Guardant Health common stock at an average price of $88.09 per share. This was an open-market sale reported as a non-derivative transaction.

When did the Tariq Musa insider sale in Guardant Health (GH) take place?

The insider sale took place on March 18, 2026. On that date, director Tariq Musa executed an open-market sale of 348 shares of Guardant Health common stock, as detailed in his Form 4 filing.

How many Guardant Health (GH) shares does Tariq Musa own after the sale?

Following the reported transaction, Tariq Musa directly owns 8,394 shares of Guardant Health common stock. This post-transaction holding reflects his remaining direct equity position after selling 348 shares.

Was the Tariq Musa Guardant Health (GH) transaction a buy or a sell?

The transaction was a sell. The Form 4 lists transaction code “S” and describes it as an open-market sale of 348 shares of Guardant Health common stock by director Tariq Musa.

Did the Tariq Musa Form 4 for Guardant Health (GH) involve derivatives or options?

No, the reported transaction involved only common stock. The Form 4 categorizes it as a non-derivative open-market sale, and the derivative section of the filing shows no option or warrant activity.